Operating expenses - Additional information (Details) € in Thousands |
6 Months Ended | |
|---|---|---|
|
Jun. 30, 2026
EUR (€)
employee
|
Jun. 30, 2025
EUR (€)
employee
|
|
| Disclosure of operating expenses [Line Items] | ||
| Personnel expenses other than share-based compensation | € | € 8,423 | € 12,227 |
| Number of employees | employee | 120 | 174 |
| Depreciation | € | € 611 | € 707 |
| R&D | ||
| Disclosure of operating expenses [Line Items] | ||
| Number of employees | employee | 92 | 133 |
| Administration | ||
| Disclosure of operating expenses [Line Items] | ||
| Number of employees | employee | 29 | 42 |
| Monalizumab agreement | ||
| Disclosure of operating expenses [Line Items] | ||
| Depreciation | € | € 611 | € 707 |